Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

The approach -- using a placebo when a "standard-of-care" vaccine already exists -- is contentious within the biomedical ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID-19 vaccine boosters.

Less than half of New Yorkers support inflation relief payments that will be sent out later this year, a new poll found.